Veracyte(VCYT) - 2021 Q4 - Earnings Call Presentation

veracyte. Q4 and Full Year 2021 Business & Financial Presentation February 28, 2022 Forward-Looking Statements This presentation contains forward-looking statements, including, but not limited to, our statements related to our expected total revenue and other financial and operating results for 2022 and our plans, objectives, expectations (financial and otherwise) or intentions with respect to our Prosigna, Afirma, Percepta, Envisia, LymphMark, Decipher Prostate, Percepta Nasal Swab, Percepta Genomic Atlas ...